BlackRock »

Turn Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Turn Therapeutics (TTRX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Turn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Turn Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Turn Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2026-06-30 $282k 39k 7.30

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for BlackRock

Top funds holding Turn Therapeutics

Steel Peak Wealth Management
Ieq Capital
DDFG
Vanguard Capital Management
Wellington Shields & Co
Millennium Management
BlackRock
Aaron Wealth Advisors
Tamar Securities
Royal Bank of Canada
Bridgewater Advisors
Citadel Advisors
Brown Brothers Harriman & Co.
HighTower Advisors
RVW Wealth

View all funds holding Turn Therapeutics